Selected research
Industry Research
Ovarian Reserve Testing Industry Research Report 2026
Market perspective
The global Ovarian Reserve Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Ovarian Reserve Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Ovarian Reserve Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Ovarian Reserve Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Ovarian Reserve Testing include VIDAS, Modern Fertility, LetsGetChecked, LabCorp, Future Family, Fujirebio, F. Hoffmann-La Roche Ltd, Everlywell and EggQ and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Ovarian Reserve Testing market in terms of revenue (US$ million) and, where applicable, service volume (Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Ovarian Reserve Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ovarian Reserve Testing Market by Company
VIDAS
Modern Fertility
LetsGetChecked
LabCorp
Future Family
Fujirebio
F. Hoffmann-La Roche Ltd
Everlywell
EggQ
Beckman Coulter
Ovarian Reserve Testing Segment by Type
Follicle Stimulating Hormone (FSH) Testing
Antral Follicle Count Testing
Basal Follicle Stimulating Hormone Testing
Anti-Mullerian hormone (AMH) Testing
Ovarian Reserve Testing Segment by Application
Hospital
Clinic
Ovarian Reserve Testing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ovarian Reserve Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ovarian Reserve Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ovarian Reserve Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Ovarian Reserve Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Follicle Stimulating Hormone (FSH) Testing
- Antral Follicle Count Testing
- Basal Follicle Stimulating Hormone Testing
- Anti-Mullerian hormone (AMH) Testing
Applications
- Hospital
- Clinic
Companies covered
- VIDAS
- Modern Fertility
- LetsGetChecked
- LabCorp
- Future Family
- Fujirebio
- F. Hoffmann-La Roche Ltd
- Everlywell
- EggQ
- Beckman Coulter
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Ovarian Reserve Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Follicle Stimulating Hormone (FSH) Testing
- 2.2.3 Antral Follicle Count Testing
- 2.2.4 Basal Follicle Stimulating Hormone Testing
- 2.2.5 Anti-Mullerian hormone (AMH) Testing
- 2.3 Ovarian Reserve Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.4 Assumptions and Limitations
3 Ovarian Reserve Testing Breakdown Data by Type
- 3.1 Global Ovarian Reserve Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Ovarian Reserve Testing Forecasted Market Size by Type (2027-2032)
4 Ovarian Reserve Testing Breakdown Data by Application
- 4.1 Global Ovarian Reserve Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Ovarian Reserve Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Ovarian Reserve Testing Market Perspective (2021-2032)
- 5.2 Global Ovarian Reserve Testing Growth Trends by Region
- 5.2.1 Global Ovarian Reserve Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Ovarian Reserve Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Ovarian Reserve Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Ovarian Reserve Testing Market Dynamics
- 5.3.1 Ovarian Reserve Testing Industry Trends
- 5.3.2 Ovarian Reserve Testing Market Drivers
- 5.3.3 Ovarian Reserve Testing Market Challenges
- 5.3.4 Ovarian Reserve Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Ovarian Reserve Testing Players by Revenue
- 6.1.1 Global Top Ovarian Reserve Testing Players by Revenue (2021-2026)
- 6.1.2 Global Ovarian Reserve Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Ovarian Reserve Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Ovarian Reserve Testing Head Office and Area Served
- 6.4 Global Ovarian Reserve Testing Players, Product Type & Application
- 6.5 Global Ovarian Reserve Testing Manufacturers Established Date
- 6.6 Global Ovarian Reserve Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Ovarian Reserve Testing Market Size (2021-2032)
- 7.2 North America Ovarian Reserve Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Ovarian Reserve Testing Market Size by Country (2021-2026)
- 7.4 North America Ovarian Reserve Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Ovarian Reserve Testing Market Size (2021-2032)
- 8.2 Europe Ovarian Reserve Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Ovarian Reserve Testing Market Size by Country (2021-2026)
- 8.4 Europe Ovarian Reserve Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Ovarian Reserve Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Ovarian Reserve Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Ovarian Reserve Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Ovarian Reserve Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Ovarian Reserve Testing Market Size (2021-2032)
- 10.2 South America Ovarian Reserve Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Ovarian Reserve Testing Market Size by Country (2021-2026)
- 10.4 South America Ovarian Reserve Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Ovarian Reserve Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Ovarian Reserve Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Ovarian Reserve Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Ovarian Reserve Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 VIDAS
- 12.1.1 VIDAS Company Information
- 12.1.2 VIDAS Business Overview
- 12.1.3 VIDAS Revenue in Ovarian Reserve Testing Business (2021-2026)
- 12.1.4 VIDAS Ovarian Reserve Testing Product Portfolio
- 12.1.5 VIDAS Recent Developments
- 12.2 Modern Fertility
- 12.2.1 Modern Fertility Company Information
- 12.2.2 Modern Fertility Business Overview
- 12.2.3 Modern Fertility Revenue in Ovarian Reserve Testing Business (2021-2026)
- 12.2.4 Modern Fertility Ovarian Reserve Testing Product Portfolio
- 12.2.5 Modern Fertility Recent Developments
- 12.3 LetsGetChecked
- 12.3.1 LetsGetChecked Company Information
- 12.3.2 LetsGetChecked Business Overview
- 12.3.3 LetsGetChecked Revenue in Ovarian Reserve Testing Business (2021-2026)
- 12.3.4 LetsGetChecked Ovarian Reserve Testing Product Portfolio
- 12.3.5 LetsGetChecked Recent Developments
- 12.4 LabCorp
- 12.4.1 LabCorp Company Information
- 12.4.2 LabCorp Business Overview
- 12.4.3 LabCorp Revenue in Ovarian Reserve Testing Business (2021-2026)
- 12.4.4 LabCorp Ovarian Reserve Testing Product Portfolio
- 12.4.5 LabCorp Recent Developments
- 12.5 Future Family
- 12.5.1 Future Family Company Information
- 12.5.2 Future Family Business Overview
- 12.5.3 Future Family Revenue in Ovarian Reserve Testing Business (2021-2026)
- 12.5.4 Future Family Ovarian Reserve Testing Product Portfolio
- 12.5.5 Future Family Recent Developments
- 12.6 Fujirebio
- 12.6.1 Fujirebio Company Information
- 12.6.2 Fujirebio Business Overview
- 12.6.3 Fujirebio Revenue in Ovarian Reserve Testing Business (2021-2026)
- 12.6.4 Fujirebio Ovarian Reserve Testing Product Portfolio
- 12.6.5 Fujirebio Recent Developments
- 12.7 F. Hoffmann-La Roche Ltd
- 12.7.1 F. Hoffmann-La Roche Ltd Company Information
- 12.7.2 F. Hoffmann-La Roche Ltd Business Overview
- 12.7.3 F. Hoffmann-La Roche Ltd Revenue in Ovarian Reserve Testing Business (2021-2026)
- 12.7.4 F. Hoffmann-La Roche Ltd Ovarian Reserve Testing Product Portfolio
- 12.7.5 F. Hoffmann-La Roche Ltd Recent Developments
- 12.8 Everlywell
- 12.8.1 Everlywell Company Information
- 12.8.2 Everlywell Business Overview
- 12.8.3 Everlywell Revenue in Ovarian Reserve Testing Business (2021-2026)
- 12.8.4 Everlywell Ovarian Reserve Testing Product Portfolio
- 12.8.5 Everlywell Recent Developments
- 12.9 EggQ
- 12.9.1 EggQ Company Information
- 12.9.2 EggQ Business Overview
- 12.9.3 EggQ Revenue in Ovarian Reserve Testing Business (2021-2026)
- 12.9.4 EggQ Ovarian Reserve Testing Product Portfolio
- 12.9.5 EggQ Recent Developments
- 12.10 Beckman Coulter
- 12.10.1 Beckman Coulter Company Information
- 12.10.2 Beckman Coulter Business Overview
- 12.10.3 Beckman Coulter Revenue in Ovarian Reserve Testing Business (2021-2026)
- 12.10.4 Beckman Coulter Ovarian Reserve Testing Product Portfolio
- 12.10.5 Beckman Coulter Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst